Partial functional correction of xeroderma pigmentosum group A cells by suppressor tRNA.
Genetic diseases are often caused by nonsense mutations. The resulting defect in protein translation can be restored by expressing suppressor tRNA in the mutant cells. Our goal was to demonstrate both protein restoration and phenotypic correction using these small transgenes. Functional activity of an arginine opal suppressor tRNA in cells expressing a nonsense mutated GFP gene was demonstrated by restored fluorescence. This suppressor tRNA was expressed in xeroderma pigmentosum group A cells, containing a homozygous nonsense mutation at Arg-207 in the XPA complementing gene. The transfected XPA cell population showed a twofold increase in cell survival after UV irradiation as determined by colony-forming assays compared with cell populations without the suppressor tRNA gene. The UV doses required for 37% survival of XP cells and XP cells expressing the suppressor tRNA were 0.6 and 1.2 J/m2. A similar twofold increase in the reactivation of UV-irradiated plasmid DNA was observed in XP cells expressing the suppressor tRNA. However, there was no detectable increase in XPA protein levels. Several potential limitations of this approach exist, including the availability of mutant RNA transcripts, the efficiency of suppression by the suppressor tRNA, and the abundance and availability and continued expression of the suppressor tRNA. The unique feature of this study is the relatively small size (88 bp) of the suppressor tRNA. Small-sized suppressor tRNAs can be synthetically constructed and subcloned into different viral vectors for delivery into the target cells. This approach may be useful for other genetic diseases caused by nonsense mutations.
Panchal
R G
RG
Human Gene Therapy Research Institute, Des Moines, IA 50309, USA.
Wang
S
S
McDermott
J
J
Link
C J
CJ
D002460:Cell Line; D002470:Cell Survival / Q000528:radiation effects; D004268:DNA-Binding Proteins / Q000235:genetics*; D018014:Gene Transfer Techniques; D018259:Herpesvirus 1, Human / Q000235:genetics; D006801:Humans; D017354:Point Mutation; D012347:RNA, Transfer, Arg / Q000096:biosynthesis* / Q000235:genetics; D013489:Suppression, Genetic; D014162:Transfection; D014466:Ultraviolet Rays; D014983:Xeroderma Pigmentosum / Q000235:genetics / Q000378:metabolism / Q000473:pathology*; D051760:Xeroderma Pigmentosum Group A Protein
D004268:DNA-Binding Proteins; D012347:RNA, Transfer, Arg; C497314:XPA protein, human; D051760:Xeroderma Pigmentosum Group A Protein